Nimbus Wadjet, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. (NCT06898450) | Nimbus Wadjet, Inc. | 2025-03-31 |
Track Nimbus Wadjet, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.